DNA Sequencing to Detect Residual Disease in Adults With Acute Myeloid Leukemia Prior to Hematopoietic Cell Transplant2024-08-02T14:22:45-07:00March 7th, 2023|Read more
Minimal/Measurable Residual Disease (MRD) Monitoring in Patients with Lymphoid Neoplasms by High-Throughput Sequencing of the T-Cell Receptor2023-04-10T20:24:04-07:00March 2nd, 2023|Read more
Comparing Data Generated Using Multiparametric Flow Cytometry, Capillary Electrophoresis, and Next-Generation Sequencing in a Cohort of B-Cell Lymphoproliferative Disorder Samples2022-12-29T21:22:21-08:00November 15th, 2022|Read more
LymphoTrack Is Equally Sensitive as PCR GeneScan and Sanger Sequencing for Detection of Clonal Rearrangements in ALL Patients2022-12-29T21:19:31-08:00June 4th, 2022|Read more
Immunoglobulin Heavy Chain High-Throughput Sequencing in Pediatric B-Precursor Acute Lymphoblastic Leukemia: Is the Clonality of the Disease at Diagnosis Related to Its Prognosis?2023-01-08T18:20:36-08:00May 30th, 2022|Read more
Hitachi High-Tech and Invivoscribe partner to advance molecular diagnostics and precision medicine2025-08-26T08:08:16-07:00May 9th, 2022|Read more
Roswell Park Comprehensive Cancer Center Licenses Invivoscribe’s LymphoTrack Software for Plug and Play Pipeline Use2026-03-09T18:50:30-07:00September 2nd, 2021|Read more
Invivoscribe Announces Key Submission in the EU, Expanded Presence and Activity in China2021-07-22T17:27:56-07:00July 22nd, 2021|Read more
Invivoscribe Launches Grant Program to Support Novel Applications for Sequence-Based Analyses of the Immune System2025-08-26T08:18:25-07:00June 24th, 2021|Read more
Invivoscribe Premieres 12-Color Flow Cytometry Capabilities at their Reference Labs in the US, Europe, and China2026-03-09T18:08:11-07:00June 3rd, 2021|Read more